{
    "N/R/U": null,
    "Applicant": "Novo Nordisk Inc.",
    "BLA Number": "125671",
    "Proprietary Name": "Esperoct",
    "Proper Name": "Antihemophilic Factor (Recombinant), GlycoPEGylated-exei",
    "BLA Type": "351(a)",
    "Strength": "3000IU",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "19-Feb-19",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1261",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}